logo
logo

Shape Memory Medical Inc. raised $38M in a Series C financing led by Earlybird Venture Capital to accelerate the clinical and market development of shape memory polymer technology for aortic and peripheral vascular markets.

Shape Memory Medical Inc. raised $38M in a Series C financing led by Earlybird Venture Capital to accelerate the clinical and market development of shape memory polymer technology for aortic and peripheral vascular markets.

03/04/24, 6:08 PM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsan jose
Money raised
$38 million
Industry
manufacturing
medical device
biotechnology
health care
Round Type
series c
Investors
Emergent Medical Partners Ii, L.P., Hbm Medfocus Llc, Wex Med Ii Llc, Hbm Healthcare Investments (Cayman) Ltd., Earlybird Venture Capital
Shape Memory Medical Inc. completed a $38 million Series C financing round led by Earlybird Venture Capital, with participation from new and existing investors including HBM Healthcare Investments (Cayman) Ltd., WexMed II LLC, HBM-Medfocus LLC, and Emergent Medical Partners II, L.P. The funding will be used to accelerate the clinical and market development of shape memory polymer technology for aortic and peripheral vascular markets.

Company Info

Company
Shape Memory Medical
Location
1321 ridder park drive, suite 10
san jose, california, united states
Additional Info
Shape Memory Medical Inc. is a developer of custom shape memory polymers for endovascular markets, dedicated to developing innovative therapeutic solutions with its proprietary shape memory polymers, with devices approved in more than 25 countries.

Related People